M.A. Larkin group of the Conway Institute of Biomolecular and Biomedical
Research, University College Dublin, Ireland (http://www.clustal.org/clustal2/)) to analyze the structural differences among various viral strains and to find the most appropriate immune response foci, which would be suitable for inducing protective antibodies. 1 As noted in our study, one of our aims was to effectively improve the current reverse genetic procedure of vaccine development. We speculated that the combined information of global surveillance, including data from the CDC (Taiwan), CDC (USA), World Health Organization, and Google Flu Trends, might speed up vaccine development and in turn save more lives. 
